Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2024 ∙ Motamed, H. Yari, F. Javadirad, E. Golmohammadi, S. Alimoradi, S. Naleini, R. Chegene Lorestani, R. Nemati Zargaran, F. Rostamian, M.

Human vaccine candidates for infections caused by Klebsiella pneumoniae: A systematic review

  • All age groups
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Li, X. Z. Li, Y. W. Huang, C. Y. Liu, J. L. Liu, R. B. Zhang, Z. X. Yan, J. Z. Zhang, C.

Humoral immunity and safety of respiratory virus vaccines in systemic lupus erythematosus population: a meta-analysis based on twenty-five observational studies

  • Adults
  • Older adults
  • COVID-19
  • Influenza
  • Efficacy/effectiveness
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Ferrara, P. Losa, L. Mantovani, L. G. Ambrosioni, J. Aguero, F.

Humoral immunogenicity of primary yellow fever vaccination in infants and children: a systematic review, meta-analysis and meta-regression

  • Newborn
  • Children
  • Yellow fever
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Kong, W. Y. Oh, N. L. Kennedy, K. L. Carlson, R. B. Liu, A. Ozawa, S. Brewer, N. T. Gilkey, M. B.

Identifying Healthcare Professionals With Lower Human Papillomavirus (HPV) Vaccine Recommendation Quality: A Systematic Review

  • Americas
  • United States of America
  • Healthcare workers
  • Human papillomavirus (HPV)
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Alper, L. Oron, Y. Handzel, O. Abu-Eta, R. Muhanna, N. Ungar, O. J.

Idiopathic sudden sensorineural hearing loss after COVID-19 vaccination: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Lamichhane, P. Khalid, H. Siviyachan, C. K. Zafar, S. Prasanth, M. Khanal, K. Agrawal, A. Kaur Jhajj, L.

Immediate impacts of COVID-19 vaccination on glycemic control in type 1 diabetes mellitus: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Hua, T. Fan, R. Fan, Y. Chen, F.

Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Olakunde, B. O. Ifeorah, I. M. Adeyinka, D. A. Olakunde, O. A. Ogundipe, T. Olawepo, J. O. Ezeanolue, E. E.

Immune response to hepatitis B vaccine among children under 5 years in Africa: a meta-analysis

  • Africa
  • Children
  • Newborn
  • Hepatitis B
  • Efficacy/effectiveness
  • Administration
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Chue, W. X. Lienardi, L. A. Tan, T. Q. W. Kadir, I. A. Lam, J. C. M.

Immune thrombocytopenia exacerbation post COVID-19 vaccination: a systematic review and meta-analysis

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Zemariam, A. B. Abebe, G. K. Kassa, M. A. Alamaw, A. W. Molla, R. W. Abate, B. B. Tilahun, B. D. Wondie, W. T. Shimelash, R. A. Fentanew, M.

Immunization coverage and its associated factors among children aged 12-23 months in Ethiopia: An umbrella review of systematic review and meta-analysis studies

  • Africa
  • Ethiopia
  • Children
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
Loading...